Childhood Arthritis and Rheumatology Research Alliance Biologic Disease-Modifying Antirheumatic Drug Consensus Treatment Plans for Refractory Moderately Severe Juvenile Dermatomyositis.
Tarvin SE, Sherman MA, Kim H, Balmuri N, Brown AG, Chow A, Gewanter HL, de Guzman MM, Huber AM, Kim S, Klein-Gitelman MS, Perron MM, Robinson AB, Sabbagh SE, Savani S, Shenoi S, Spitznagle J, Stingl C, Syverson G, Tory H, Spencer C; Childhood Arthritis and Rheumatology Research Alliance Juvenile Dermatomyositis Workgroup.
Tarvin SE, et al. Among authors: balmuri n.
Arthritis Care Res (Hoboken). 2024 Nov;76(11):1532-1539. doi: 10.1002/acr.25393. Epub 2024 Aug 14.
Arthritis Care Res (Hoboken). 2024.
PMID: 38937134